Skip to main content
Top
Published in: Intensive Care Medicine 6/2012

01-06-2012 | Original

Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care

Authors: E. Schaden, P. G. Metnitz, G. Pfanner, S. Heil, T. Pernerstorfer, P. Perger, H. Schoechl, D. Fries, M. Guetl, S. Kozek-Langenecker

Published in: Intensive Care Medicine | Issue 6/2012

Login to get access

Abstract

Purpose

Venous thromboembolism (VTE) is a common but often overlooked life-threatening complication of critical illness. The aim of this cross-sectional survey was to assess current practice of thromboprophylaxis as well as adherence to international guidelines.

Methods

After ethics committee approval, all intensive care units in Austrian hospitals treating adult patients were invited to participate in this web-based survey. Anonymized data on each patient treated at the participating intensive care units on Coagulation Day 2010 were collected using an electronic case report form. Risk assessment, choice and monitoring of anticoagulants, means of mechanical prophylaxis, and demographic data were recorded.

Results

Data from 325 critically ill patients were collected. Patients had a median of four risk factors for thrombosis and 6 % suffered from VTE. Of the 325 patients, 80 % received low molecular weight heparins subcutaneously, 10 % received unfractionated heparin intravenously, 1 % received alternative anticoagulants and 9 % received no pharmacological prophylaxis. Mechanical prophylaxis was used in 49 % with a predominant use of graduated compression stockings. In 39 % a combination of pharmacological and mechanical prophylaxis was applied and 5 % received no prophylaxis at all. Overall guideline adherence was 40 % on Coagulation Day 2010.

Conclusion

Current practice of thromboprophylaxis is predominantly based on the administration of low molecular weight heparins prescribed at rather arbitrary doses without a discernible relationship to drug monitoring, thromboembolic risk factors, vasopressor use or fluid balance. The use of mechanical prophylaxis, evaluation of risk scores and overall guideline adherence must be further encouraged by education, training and communication.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levi M (2008) Hemostasis and thrombosis in critically ill patients. Semin Thromb Hemost 34:415–416PubMedCrossRef Levi M (2008) Hemostasis and thrombosis in critically ill patients. Semin Thromb Hemost 34:415–416PubMedCrossRef
2.
go back to reference Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ; American College of Chest Physicians (2008) Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):110S–112SPubMedCrossRef Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ; American College of Chest Physicians (2008) Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):110S–112SPubMedCrossRef
3.
go back to reference Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–16PubMed Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–16PubMed
4.
5.
go back to reference Dörffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Büller HR, Levi M (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359:849–850PubMedCrossRef Dörffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Büller HR, Levi M (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359:849–850PubMedCrossRef
6.
go back to reference Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM (2006) Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care 10:R93PubMedCrossRef Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM (2006) Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care 10:R93PubMedCrossRef
8.
go back to reference Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE) (2007) Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764PubMed Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE) (2007) Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764PubMed
9.
go back to reference Crowther MA, Cook DJ (2008) Preventing venous thromboembolism in critically ill patients. Semin Thromb Hemost 34:469–474PubMedCrossRef Crowther MA, Cook DJ (2008) Preventing venous thromboembolism in critically ill patients. Semin Thromb Hemost 34:469–474PubMedCrossRef
10.
go back to reference Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun-Buisson C; French and Canadian ICU Directors Groups (2003) Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care 18:228–237PubMedCrossRef Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun-Buisson C; French and Canadian ICU Directors Groups (2003) Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care 18:228–237PubMedCrossRef
11.
go back to reference Imberti D, Ageno W (2005) A survey of thromboprophylaxis management in patients with major trauma. Pathophysiol Haemost Thromb 34:249–254PubMedCrossRef Imberti D, Ageno W (2005) A survey of thromboprophylaxis management in patients with major trauma. Pathophysiol Haemost Thromb 34:249–254PubMedCrossRef
12.
go back to reference Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:CD005258 Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:CD005258
13.
go back to reference Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 7:CD001484PubMed Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 7:CD001484PubMed
14.
go back to reference Fritz E, Them C, Hackl JM (2005) Routine nursing measures for thrombosis prevention in an university hospital. Pflege 18:43–50PubMedCrossRef Fritz E, Them C, Hackl JM (2005) Routine nursing measures for thrombosis prevention in an university hospital. Pflege 18:43–50PubMedCrossRef
15.
go back to reference Eisele R, Kinzl L, Koelsch T (2007) Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. J Bone Joint Surg Am 89:1050–1056PubMedCrossRef Eisele R, Kinzl L, Koelsch T (2007) Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. J Bone Joint Surg Am 89:1050–1056PubMedCrossRef
16.
go back to reference Robinson S, Zincuk A, Strøm T, Larsen TB, Rasmussen B, Toft P (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41PubMedCrossRef Robinson S, Zincuk A, Strøm T, Larsen TB, Rasmussen B, Toft P (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41PubMedCrossRef
18.
go back to reference Bara L, Leizorovicz A, Picolet H, Samama MM (1992) Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group. Thromb Res 65:641–650PubMedCrossRef Bara L, Leizorovicz A, Picolet H, Samama MM (1992) Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group. Thromb Res 65:641–650PubMedCrossRef
19.
go back to reference Leizorovicz A, Bara L, Samama MM, Haugh MC (1993) Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis 23(Suppl 1):89–98PubMed Leizorovicz A, Bara L, Samama MM, Haugh MC (1993) Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis 23(Suppl 1):89–98PubMed
20.
go back to reference Bara L, Planes A, Samama MM (1999) Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 104:230–240PubMedCrossRef Bara L, Planes A, Samama MM (1999) Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 104:230–240PubMedCrossRef
21.
go back to reference Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M (1994) A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 154:49–56PubMedCrossRef Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M (1994) A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 154:49–56PubMedCrossRef
22.
go back to reference Levy JH, Key NS, Azran MS (2010) Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology 113:726–745PubMed Levy JH, Key NS, Azran MS (2010) Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology 113:726–745PubMed
23.
go back to reference Schaden E, Schober A, Hacker S, Spiss C, Chiari A, Kozek-Langenecker S (2010) Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis 21:256–261PubMedCrossRef Schaden E, Schober A, Hacker S, Spiss C, Chiari A, Kozek-Langenecker S (2010) Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis 21:256–261PubMedCrossRef
24.
go back to reference Cook DJ, Crowther MA, Meade MO, Douketis J (2005) Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care 20:309–313PubMedCrossRef Cook DJ, Crowther MA, Meade MO, Douketis J (2005) Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care 20:309–313PubMedCrossRef
25.
go back to reference Hilbert P, Teumer P, Stuttmann R (2008) Prevention of thromboembolism in German intensive care units: results of a nationwide survey. Anaesthesist 57:242–250PubMedCrossRef Hilbert P, Teumer P, Stuttmann R (2008) Prevention of thromboembolism in German intensive care units: results of a nationwide survey. Anaesthesist 57:242–250PubMedCrossRef
Metadata
Title
Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care
Authors
E. Schaden
P. G. Metnitz
G. Pfanner
S. Heil
T. Pernerstorfer
P. Perger
H. Schoechl
D. Fries
M. Guetl
S. Kozek-Langenecker
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 6/2012
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2533-0

Other articles of this Issue 6/2012

Intensive Care Medicine 6/2012 Go to the issue